DA Ahlquist, HS Wieand, CG Moertel, DB … - Jama, 1993 - Am Med Assoc OBJECTIVES--To define the validity of fecal blood as a marker for colorectal
neoplasia in the screening setting and to compare yields by Hemoccult and
HemoQuant fecal occult blood screening tests. DESIGN--A multicenter masked ... Cited by 296 - Related articles - BL Direct - All 6 versions
DA Ahlquist, AP Shuber - Clinica Chimica Acta, 2002 - Elsevier Background: Colorectal cancer is the second leading cause of malignant death,
and better preventive strategies are needed. Participation rates for colorectal
cancer screening remain low due, in part, to perceived discomfort, ... Cited by 108 - Related articles - All 5 versions
NK Osborn, DA Ahlquist - Gastroenterology, 2005 - Elsevier Assay of molecular markers in stool represents a promising noninvasive approach
to screen colorectal cancer. Given that neoplasms exfoliate abundantly into the
lumen and that DNA recovered from stool can be assayed with sensitive ... Cited by 105 - Related articles - All 14 versions
- ►clinchem.org [PDF] S Schwartz, J Dahl, M Ellefson, D Ahlquist - Clinical Chemistry, 1983 - Am Assoc Clin Chem We describe a new, specific, quantitative method for fecal blood, based on
conversion of nonfluorescing heme to fluorescing porphyrins, that obviates
serious deficiencies inherent in currently used tests. A two-reagent system ... Cited by 86 - Related articles - All 4 versions
DA Ahlquist - Gastroenterology Clinics of North America, 1997 - Elsevier A biologic rationale for colorectal cancer screening is provided by the long
dwell time of premalignant adenomas and presymptomatic curative-stage
carcinomas. An ideal screening intervention would effectively, efficiently, ... Cited by 68 - Related articles - BL Direct - All 4 versions
PJ Limburg, DA Ahlquist, WJ Sandborn, DW … - The American journal of gastroenterology, 2000 - interscience.wiley.com OBJECTIVE: Chronic diarrhea is a relatively common condition with multiple
diverse etiologies. Stool testing may serve as a diagnostic aid to discriminate
the presence or absence of organic pathology, such as colorectal ... Cited by 70 - Related articles - BL Direct - All 6 versions
DA Ahlquist, DB McGill, JL Fleming, S … - CA A Cancer Journal for Clinicians - interscience.wiley.com The assumption that asymptomatic colorectal cancers bleed provides the rationale
for widespread stool screening. The authors studied 12 patients with unoperated
colorectal cancer but without colorectal symptoms and six healthy ... Cited by 69 - Related articles - All 2 versions
PD Greenberg, JP Cello, DC Rockey - The American journal of medicine, 1996 - Elsevier Patients taking no aspirin had mean fecal blood of 0.68 ± 0.05 mg hemoglobin/g
stool, which increased to 1.41 ± 0.36 mg/g after taking 325 mg of aspirin daily
(P = 0.02). In contrast, patients in group 2, taking 81 mg and 325 mg of ... Cited by 50 - Related articles - All 7 versions
PJ Limburg, ME Devens, JJ Harrington, NN … - The American journal of gastroenterology, 2003 - nature.com Stool testing is a well established method of screening for colorectal
neoplasia. Emerging data suggest that novel biomarkers may offer performance
advantages over fecal occult blood. In this large, prospective study, we ... Cited by 43 - Related articles - BL Direct - All 6 versions
- ►nih.gov [PDF] JD Robertson, RJ Maughan, RJ Davidson - British Medical Journal, 1987 - bmj.com Page 1. doi:10.1136/bmj.295.6593.303 1987;295;303-305 Br Med J (Clin Res Ed) JD
Robertson, RJ Maughan and RJ Davidson Faecal blood loss in response to exercise. ... Cited by 33 - Related articles - All 5 versions
